KALA BIO, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KALA research report →
About the company
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs).
- CEO
- Avi Minkowitz
- IPO
- 2017
- Employees
- 38
- HQ
- Arlington, MA, US
Price Chart
- Market Cap
- $36.84M
- P/E
- -0.58
- P/S
- 0.00
- P/B
- 1.27
- EV/EBITDA
- -2.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1335.64%
- ROIC
- -281.52%
- Revenue
- $0 · 0.00%
- Net Income
- $-26,980,000 · 29.94%
- EPS
- $-3.31 · 52.58%
- Op Income
- $-39,161,000
- FCF YoY
- -8.11%
- 52W High
- $1030.00
- 52W Low
- $1.62
- 50D MA
- $3.43
- 200D MA
- $64.39
- Beta
- -2.41
- Avg Volume
- 107.57K
Get TickerSpark's AI analysis on KALA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 30, 26 | Purdy Brendan P. | other | 0 |
| Jan 30, 26 | Posen Hillel D. | other | 0 |
| Jan 30, 26 | Minkowitz Avraham | other | 0 |
| Jan 30, 26 | Colman Yonatan C. | other | 0 |
| Jan 30, 26 | Berger Chaim D. | other | 0 |
| Dec 18, 25 | Lazar David E. | other | 368,614 |
| Nov 25, 25 | OXFORD FINANCE LLC | other | 0 |
| Nov 23, 25 | Lazar David E. | other | 0 |
| Nov 9, 25 | Lazar David E. | other | 368,614 |
| Nov 24, 25 | Lazar David E. | other | 900,000 |
Our KALA coverage
Recent articles, reports, and earnings notes.
No research on KALA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KALA report →Similar companies
Peers in the same neighborhood.